Synapse - Gynecology Disease Management Team

Results (5144)

Impact of adjuvant therapy on oncologic outcomes in uterine-confined clear cell carcinoma of the endometrium

Journal Article

Rios-Doria, E.; Nobre, S. P.; Sassine, D.; Glaser, G.; Eriksson, A. G.; Ataseven, B.; du Bois, A.; Makker, V.; Alektiar, K.; Leitao, M. M.; more...
Gynecologic Oncology (2024)

Fulltext@MSK | Save

Response to the letter to the editor: Referring to the manuscript entitled “Surgical nodal assessment for endometrial hyperplasia – A meta-analysis and systematic review”

Correspondence

Nahshon, C.; Leitao, M. M. Jr; Segev, Y.
Gynecologic Oncology (2024)

Fulltext@MSK | Save

Survival associated with the use of sentinel lymph node in addition to lymphadenectomy in early-stage cervical cancer treated with surgery alone: A sub-analysis of the Surveillance in Cervical CANcer (SCCAN) collaborative study

Journal Article

Bizzarri, N.; Querleu, D.; Ramirez, P. T.; Dostálek, L.; van Lonkhuijzen, L. R. W.; Giannarelli, D.; Lopez, A.; Salehi, S.; Ayhan, A.; Kim, S. H.; more...
European Journal of Cancer (2024)

Fulltext@MSK | Save

Phase II/III study of paclitaxel/carboplatin alone or combined with either trastuzumab and hyaluronidase-oysk or pertuzumab, trastuzumab, and hyaluronidase-zzxf in HER2 positive, stage I-IV endometrial serous carcinoma or carcinosarcoma (NRG-GY026)

Meeting Abstract

Erickson, B. K.; Enserro, D.; Lankes, H. A.; Dockery, L. E.; Ghamande, S. A.; Oliver, M. T.; Gressel, G. M.; Castellano, T.; Ratner, E.; Deery, A.; more...
Journal of Clinical Oncology (2024)

Fulltext@MSK | Save

Vibostolimab coformulated with pembrolizumab (vibo/pembro) for previously treated advanced mismatch repair-deficient (dMMR) endometrial cancer: Results from cohort B1 of the phase 2 KEYVIBE-005 study

Meeting Abstract

Rojas, C.; Eskens, F.; Ghiringhelli, F.; Özgüroglu, M.; Caglevic, C.; Gumus, M.; Tosi, D.; Grenier, J.; Gonzalez, A. F.; Arenas, A.; more...
Journal of Clinical Oncology (2024)

Fulltext@MSK | Save

Phase 3 dose selection for selinexor in TP53wt endometrial cancer based on exposure-response analysis

Meeting Abstract

Makker, V.; Richardson, D. L.; Chon, H. S.; Miller, D. S.; Mau-Sorensen, M.; Cibula, D.; Zagouri, F.; Fidalgo, A. P.; Slomovitz, B. M.; Coleman, R. L.; more...
Journal of Clinical Oncology (2024)

Fulltext@MSK | Save

Dose-expansion part of a phase 1b global study of E7386 in combination with lenvatinib (LEN) in patients (pts) with hepatocellular carcinoma (HCC) and other solid tumors including endometrial cancer (EC)

Meeting Abstract

Lee, J. Y.; Ryoo, B. Y.; Kim, J. W.; Cheng, A. L.; Finn, R. S.; Hasegawa, K.; Makker, V.; Kudo, M.; Miller, D. S.; Merle, P.; more...
Journal of Clinical Oncology (2024)

Fulltext@MSK | Save

Phase 1 safety and efficacy of IMC-F106C, a PRAME x CD3 ImmTAC bispecific, in post-checkpoint cutaneous melanoma (CM)

Meeting Abstract

Hamid, O.; Williams, A.; Lopez, J. S.; Olson, D.; Sato, T.; Shaw, H. M.; Friedman, C. F.; Thistlethwaite, F.; Middleton, M. R.; Lebbe, C.; more...
Journal of Clinical Oncology (2024)

Fulltext@MSK | Save

Efficacy and safety of trastuzumab deruxtecan (T-DXd) in patients (pts) with HER2-expressing solid tumors: Results from the bladder cohort of the DESTINY-PanTumor02 (DP-02) study

Meeting Abstract

Wysocki, P. J.; Jung, K. H.; Oh, D. Y.; Doroshow, D. B.; Artamonova, E.; Mammatas, L.; Su, P. J.; Moiseyenko, V.; Penkov, K.; Stroyakovskiy, D.; more...
Journal of Clinical Oncology (2024)

Fulltext@MSK | Save

Racial/ethnic distribution of participants in NRG oncology clinical trials: 2014-2023

Meeting Abstract

Dignam, J. J.; Romitti, P. A.; Yom, S. S.; Feng, F. Y.; Bradley, J. D.; Mehta, M. P.; Bruner, D. W.; Wenzel, J.; Mamounas, E. P.; George, T. J.; more...
Journal of Clinical Oncology (2024)

Fulltext@MSK | Save